A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases

Table 1 Clinicopathology of patients used for patient-derived organoids

Patient no.	Age, yr	Gender	CEA, ng/ml	Tumor location	TNM stage	Metastatic organ
mCRC
1#	60	Female	2644.3	Sigmoid	IV	Liver
2#	61	Male	122.4	Rectum	IV	Liver, Lung
3#	64	Male	546.0	Ascending	IV	Liver
4#	69	Male	3555.4	Rectum	IV	Liver
5#	64	Male	46.2	Descending	IV	Liver
6#	64	Female	3.2	Ascending	IV	Liver, Lung
CRC
7#	69	Male	77.3	Rectum	III	None
8#	64	Male	14.6	Descending	III	None
9#	67	Male	262.8	Sigmoid	III	None
10#	64	Female	5.3	Ascending	III	None
11#	65	Female	36.6	Rectum	II	None
12#	69	Male	4.4	Sigmoid	II	None

ISSN: 1479-5876